GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Jiangsu Yangnong Chemical Co 600486.SS · CNY

Materials · Shanghai · 🇨🇳 China

Compare

55.82

-1.20%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥11.87bn

FY2016FY2025

Net income

CN¥1.29bn

FY2016FY2025

Free cash flow

CN¥1.26bn

FY2016FY2025

Shareholders' equity

CN¥11.47bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥11.87bnCN¥10.43bnCN¥11.48bnCN¥15.81bnCN¥11.84bnCN¥9.83bnCN¥8.70bnCN¥8.58bnCN¥4.44bnCN¥2.93bn
Gross profitCN¥3.42bnCN¥2.40bnCN¥2.91bnCN¥4.04bnCN¥2.72bnCN¥2.57bnCN¥2.49bnCN¥2.26bnCN¥1.22bnCN¥726.1m
Research and developmentCN¥392.9mCN¥358.2mCN¥418.0mCN¥498.0mCN¥373.5mCN¥332.3mCN¥319.8mCN¥317.9mCN¥211.9mCN¥139.5m
Operating incomeCN¥1.53bnCN¥1.41bnCN¥1.87bnCN¥2.15bnCN¥1.44bnCN¥1.43bnCN¥1.40bnCN¥1.20bnCN¥708.6mCN¥396.7m
Net incomeCN¥1.29bnCN¥1.20bnCN¥1.57bnCN¥1.79bnCN¥1.22bnCN¥1.21bnCN¥1.17bnCN¥979.7mCN¥575.0mCN¥439.3m
Diluted earnings per share3.202.983.884.453.943.913.773.161.851.42

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥18.19bnCN¥17.66bnCN¥15.70bnCN¥14.79bnCN¥13.10bnCN¥10.90bnCN¥9.64bnCN¥7.44bnCN¥7.08bnCN¥5.70bn
Cash and short-term investments—CN¥1.62bnCN¥3.71bnCN¥3.36bnCN¥2.27bnCN¥1.89bnCN¥2.33bnCN¥1.45bnCN¥1.19bnCN¥735.1m
Total liabilitiesCN¥6.71bnCN¥7.12bnCN¥6.03bnCN¥6.25bnCN¥6.16bnCN¥4.94bnCN¥4.58bnCN¥2.61bnCN¥3.03bnCN¥2.14bn
Debt—CN¥1.19bnCN¥363.8mCN¥818.3mCN¥1.11bnCN¥1.00bnCN¥1.34bnCN¥328.3mCN¥417.3mCN¥333.2m
Shareholders' equityCN¥11.47bnCN¥10.54bnCN¥9.67bnCN¥8.53bnCN¥6.94bnCN¥5.95bnCN¥5.05bnCN¥4.63bnCN¥3.90bnCN¥3.45bn
Shares outstanding402m404m404m403m310m310m310m310m310m310m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥2.22bnCN¥2.16bnCN¥2.40bnCN¥2.12bnCN¥1.45bnCN¥1.38bnCN¥1.37bnCN¥1.32bnCN¥1.14bnCN¥256.9m
Capital spending−CN¥961.3m−CN¥1.84bn−CN¥1.52bn−CN¥1.17bn−CN¥1.33bn−CN¥1.16bn−CN¥781.8m−CN¥604.9m−CN¥656.9m−CN¥561.5m
Free cash flowCN¥1.26bnCN¥320.1mCN¥882.6mCN¥956.9mCN¥122.3mCN¥215.2mCN¥588.3mCN¥715.3mCN¥481.8m−CN¥304.6m
Dividends paid−CN¥391.8m−CN¥372.0m−CN¥427.4m−CN¥201.4m−CN¥201.4m−CN¥201.4m−CN¥269.6m−CN¥190.2m−CN¥154.1m−CN¥146.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥3.14bnCN¥3.47bnCN¥2.71bnCN¥2.92bnCN¥2.99bnCN¥3.24bnCN¥2.42bnCN¥2.32bn
Gross profitCN¥764.6mCN¥755.6mCN¥564.0mCN¥573.2mCN¥674.5mCN¥798.5mCN¥472.5mCN¥545.5m
Operating incomeCN¥494.5mCN¥524.7mCN¥264.0mCN¥274.6mCN¥437.0mCN¥518.2mCN¥225.9mCN¥298.7m
Net incomeCN¥382.8mCN¥407.0mCN¥230.5mCN¥249.5mCN¥370.9mCN¥434.9mCN¥176.2mCN¥262.7m
Diluted earnings per share0.951.010.570.620.921.080.440.65
Cash from operations———CN¥399.0mCN¥696.0mCN¥1.03bn—CN¥501.0m
Capital spending−CN¥112.0m−CN¥198.0m−CN¥429.0m−CN¥125.0m−CN¥132.0m−CN¥273.0m−CN¥784.0m−CN¥346.0m
Free cash flow———CN¥274.0mCN¥564.0mCN¥758.0m—CN¥155.0m
Total assetsCN¥18.71bnCN¥19.12bnCN¥18.19bnCN¥18.62bnCN¥18.24bnCN¥18.08bnCN¥17.66bnCN¥17.11bn
Cash and short-term investments———CN¥1.76bnCN¥1.86bnCN¥1.84bnCN¥1.62bnCN¥1.62bn
Debt———CN¥3.13bnCN¥942.0mCN¥954.8mCN¥1.19bnCN¥296.9m
Shareholders' equityCN¥11.96bnCN¥11.87bnCN¥11.47bnCN¥11.27bnCN¥11.12bnCN¥10.98bnCN¥10.54bnCN¥10.38bn

Financial ratios

Data as of 22 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin28.8%23.0%25.4%25.6%23.0%26.2%—
Operating margin12.9%13.5%16.3%13.6%12.2%14.6%—
Net margin10.8%11.5%13.6%11.3%10.3%12.3%—
Return on equity11.2%11.4%16.2%21.0%17.6%20.3%—
Return on assets7.1%6.8%10.0%12.1%9.3%11.1%—
Free cash flow yield14.9%18.7%18.3%15.4%17.0%15.5%—
Revenue growth13.8%-9.1%-27.4%33.5%20.4%13.0%—
Earnings growth7.0%-23.2%-12.8%46.8%1.0%3.4%—
Current ratio1.38x1.08x1.58x1.61x1.37x1.55x—
Debt to equity—0.11x0.06x0.10x0.17x0.17x0.18x
Equity ratio63.1%59.6%61.6%57.7%53.0%54.6%—
Interest coverage37.01x20.77x37.42x33.82x29.31x23.77x—
R&D as a share of sales3.3%3.4%3.6%3.1%3.2%3.4%—
Buybacks as a share of market value0.3%0.0%-0.2%-30.0%-0.1%0.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-9.1%3.8%14.3%
Operating income-10.6%1.3%10.4%
Net income-10.5%1.2%10.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin26.1%25.8%25.4%25.8%
Operating margin13.2%14.0%13.8%14.3%
Net margin11.2%11.8%11.6%12.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings21.719.416.317.925.626.014.09.220.620.6
Price to sales2.42.22.22.02.63.21.91.12.73.1

Dividends and splits

Per share, in the currency the company pays

Paid for 19 years. Last went ex-dividend on 30 Sept 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.9540.920.881.300.500.500.500.669
  • 13-for-10 split · 17 Jul 2023
  • 6-for-5 split · 7 Jul 2015
  • 13-for-10 split · 20 May 2010
  • 1-to-1 reverse split · 5 Jul 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.